Using Medical Claims for Policy Effectiveness Surveillance: Reimbursement and Utilization of Abdomen/Pelvis Computed Tomography Scans

Por Horný, Michal, Morgan, Jake R., Merker, Vanessa L.
Publicado no Health Serv Res (2015)

Capsule Commentary on Tannenbaum et al., Nudging Physician Prescription Decisions by Partitioning the Order Set: Results of a Vignette-Based Study

Por Burgess, James F., Jones, Eric A., Morgan, Jake R.
Publicado no J Gen Intern Med (2014)

A Qualitative Study of the Real-world Experiences of Infectious Diseases Fellows Regarding Antibiotic Stewardship

Por Morgan, Jake R, Barlam, Tamar F, Drainoni, Mari-Lynn
Publicado no Open Forum Infect Dis (2018)

Economic evaluation of HCV testing approaches in low and middle income countries

Por Morgan, Jake R., Servidone, Maria, Easterbrook, Philippa, Linas, Benjamin P.
Publicado no BMC Infect Dis (2017)

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets

Por Morgan, Jake R, Kim, Arthur Y, Naggie, Susanna, Linas, Benjamin P
Publicado no Open Forum Infect Dis (2017)

Predictors of Frequent Emergency Room Visits among a Homeless Population

Por Thakarar, Kinna, Morgan, Jake R., Gaeta, Jessie M., Hohl, Carole, Drainoni, Mari-Lynn
Publicado no PLoS One (2015)

Homelessness, HIV, and Incomplete Viral Suppression

Por Thakarar, Kinna, Morgan, Jake R., Gaeta, Jessie M., Hohl, Carole, Drainoni, Mari-Lynn
Publicado no J Health Care Poor Underserved (2016)

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured...

Por MORGAN, Jake R., SCHACKMAN, Bruce R., LEFF, Jared A., LINAS, Benjamin P., WALLEY, Alexander Y.
Publicado no J Subst Abuse Treat (2017)

Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned

Por Murphy, Sean M., Leff, Jared A., Linas, Benjamin P., Morgan, Jake R., McCollister, Kathryn, Schackman, Bruce R.
Publicado no Subst Abus (2018)

Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs

Por Schackman, Bruce R., Gutkind, Sarah, Morgan, Jake R., Leff, Jared A., Behrends, Czarina N., Delucchi, Kevin L., McKnight, Courtney, Perlman, David C., Masson, Carmen L., Linas, Benjamin P.
Publicado no Drug Alcohol Depend (2018)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

Por Linas, Benjamin P., Morgan, Jake R., Pho, Mai T., Leff, Jared A., Schackman, Bruce R., Horsburgh, C. Robert, Assoumou, Sabrina A., Salomon, Joshua A., Weinstein, Milton C., Freedberg, Kenneth A., Kim, Arthur Y.
Publicado no Open Forum Infect Dis (2016)

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

Por Linas, Benjamin P., Barter, Devra M., Morgan, Jake R., Pho, Mai T., Leff, Jared A., Schackman, Bruce R., Horsburgh, C. Robert, Assoumou, Sabrina A., Salomon, Joshua A., Weinstein, Milton C., Freedberg, Kenneth A., Kim, Arthur Y.
Publicado no Ann Intern Med (2015)